- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Cetuximab – March 2018
Cetuximab: Solution for I.V. infusion 100 mg in 20 mL, Solution for I.V. infusion 500 mg in 100 mL; Erbitux®
Last updated
5 November 2018